795 related articles for article (PubMed ID: 23101624)
1. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel.
Kannan K; Vázquez-Laslop N; Mankin AS
Cell; 2012 Oct; 151(3):508-20. PubMed ID: 23101624
[TBL] [Abstract][Full Text] [Related]
2. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
[TBL] [Abstract][Full Text] [Related]
3. Sequence-dependent elongation dynamics on macrolide-bound ribosomes.
Johansson M; Chen J; Tsai A; Kornberg G; Puglisi JD
Cell Rep; 2014 Jun; 7(5):1534-1546. PubMed ID: 24836000
[TBL] [Abstract][Full Text] [Related]
4. Context-specific action of macrolide antibiotics on the eukaryotic ribosome.
Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS
Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the mechanism of translocation in ribosomes. V. Comparison of the effect of antibiotic inhibitors of ribosomes on "enzymatic" and "non-enzymatic" translation].
Kostiashkina OE; Asatrian LS; Gavrilova LP; Spirin AS
Mol Biol (Mosk); 1975; 9(5):775-82. PubMed ID: 765776
[TBL] [Abstract][Full Text] [Related]
6. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
Kannan K; Mankin AS
Ann N Y Acad Sci; 2011 Dec; 1241():33-47. PubMed ID: 22191525
[TBL] [Abstract][Full Text] [Related]
7. Cis-acting resistance peptides reveal dual ribosome inhibitory action of the macrolide josamycin.
Lovmar M; Vimberg V; Lukk E; Nilsson K; Tenson T; Ehrenberg M
Biochimie; 2009 Aug; 91(8):989-95. PubMed ID: 19463886
[TBL] [Abstract][Full Text] [Related]
8. On the use of the antibiotic chloramphenicol to target polypeptide chain mimics to the ribosomal exit tunnel.
Mamos P; Krokidis MG; Papadas A; Karahalios P; Starosta AL; Wilson DN; Kalpaxis DL; Dinos GP
Biochimie; 2013 Sep; 95(9):1765-72. PubMed ID: 23770443
[TBL] [Abstract][Full Text] [Related]
9. Exploiting translational stalling peptides in an effort to extend azithromycin interaction within the prokaryotic ribosome nascent peptide exit tunnel.
Washington AZ; Tapadar S; George A; Oyelere AK
Bioorg Med Chem; 2015 Aug; 23(16):5198-209. PubMed ID: 26037612
[TBL] [Abstract][Full Text] [Related]
10. Conjugates of amino acids and peptides with 5-o-mycaminosyltylonolide and their interaction with the ribosomal exit tunnel.
Shishkina A; Makarov G; Tereshchenkov A; Korshunova G; Sumbatyan N; Golovin A; Svetlov M; Bogdanov A
Bioconjug Chem; 2013 Nov; 24(11):1861-9. PubMed ID: 24090034
[TBL] [Abstract][Full Text] [Related]
11. Macrolide antibiotics allosterically predispose the ribosome for translation arrest.
Sothiselvam S; Liu B; Han W; Ramu H; Klepacki D; Atkinson GC; Brauer A; Remm M; Tenson T; Schulten K; Vázquez-Laslop N; Mankin AS
Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9804-9. PubMed ID: 24961372
[TBL] [Abstract][Full Text] [Related]
12. The general mode of translation inhibition by macrolide antibiotics.
Kannan K; Kanabar P; Schryer D; Florin T; Oh E; Bahroos N; Tenson T; Weissman JS; Mankin AS
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):15958-63. PubMed ID: 25349425
[TBL] [Abstract][Full Text] [Related]
13. Direct Measurements of Erythromycin's Effect on Protein Synthesis Kinetics in Living Bacterial Cells.
Seefeldt AC; Aguirre Rivera J; Johansson M
J Mol Biol; 2021 May; 433(10):166942. PubMed ID: 33744313
[TBL] [Abstract][Full Text] [Related]
14. Enhanced SnapShot: Antibiotic inhibition of protein synthesis II.
Sohmen D; Harms JM; Schlünzen F; Wilson DN
Cell; 2009 Oct; 139(1):212-212.e1. PubMed ID: 19804764
[TBL] [Abstract][Full Text] [Related]
15. Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome.
Seefeldt AC; Graf M; Pérébaskine N; Nguyen F; Arenz S; Mardirossian M; Scocchi M; Wilson DN; Innis CA
Nucleic Acids Res; 2016 Mar; 44(5):2429-38. PubMed ID: 26792896
[TBL] [Abstract][Full Text] [Related]
16. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.
Llano-Sotelo B; Dunkle J; Klepacki D; Zhang W; Fernandes P; Cate JH; Mankin AS
Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725
[TBL] [Abstract][Full Text] [Related]
17. On the mechanism of action of 9-O-arylalkyloxime derivatives of 6-O-mycaminosyltylonolide, a new class of 16-membered macrolide antibiotics.
Karahalios P; Kalpaxis DL; Fu H; Katz L; Wilson DN; Dinos GP
Mol Pharmacol; 2006 Oct; 70(4):1271-80. PubMed ID: 16873579
[TBL] [Abstract][Full Text] [Related]
18. Context-Specific Action of Ribosomal Antibiotics.
Vázquez-Laslop N; Mankin AS
Annu Rev Microbiol; 2018 Sep; 72():185-207. PubMed ID: 29906204
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of mammalian mitochondrial translation.
Zhang L; Ging NC; Komoda T; Hanada T; Suzuki T; Watanabe K
FEBS Lett; 2005 Nov; 579(28):6423-7. PubMed ID: 16271719
[TBL] [Abstract][Full Text] [Related]
20. Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics.
Beckert B; Leroy EC; Sothiselvam S; Bock LV; Svetlov MS; Graf M; Arenz S; Abdelshahid M; Seip B; Grubmüller H; Mankin AS; Innis CA; Vázquez-Laslop N; Wilson DN
Nat Commun; 2021 Jul; 12(1):4466. PubMed ID: 34294725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
